Management of INR 1.8 with Missed Coumadin Dose
Continue the patient's current warfarin maintenance dose without adjustment and recheck the INR within 1-2 weeks. The missed dose explains the subtherapeutic INR of 1.8, and evidence shows no benefit from single-dose corrections in stable patients with isolated out-of-range values 1.
Rationale for No Dose Adjustment
The American College of Chest Physicians guidelines specifically address this scenario. For patients with previously stable therapeutic INRs who present with a single out-of-range INR of ≤0.5 below therapeutic range (target 2.0-3.0), continuing the current dose is recommended over making adjustments 1.
Supporting Evidence
An RCT comparing one-time dose increases versus no change for INRs between 1.5-4.4 found no significant difference in therapeutic INR achievement at 2-week follow-up (44% vs 40% out of range, OR 1.17,95% CI 0.59-2.30) 1
A large observational study of 3,961 patients demonstrated that warfarin doses did not need adjustment for INRs between 1.7-3.3 1
More recent research (2022) analyzing 45,351 slightly out-of-range INRs confirmed that watchful waiting versus dose changes showed only minimal statistical difference (58.9% vs 60.0% back in range, p=0.024) with no clinical significance 2
Management Algorithm
Immediate Actions:
- Instruct patient to resume regular warfarin dosing schedule immediately
- Do not give an extra dose to "catch up" for the missed dose 3
- Schedule INR recheck in 1-2 weeks 1
Bridging Therapy:
- Do NOT routinely bridge with heparin or LMWH for this single subtherapeutic INR 1
- Retrospective studies of 2,597 patients showed no significant difference in thromboembolic events between low-INR and therapeutic-INR cohorts 1
- Even in mechanical heart valve patients (294 patients studied), thromboembolism incidence was only 0.3-0.4% without bridging 1
Critical Caveats
Consider bridging or closer monitoring if:
- Patient has mechanical heart valve (especially mitral position or older generation valves)
- Recent VTE within past 3 months
- History of thromboembolism while anticoagulated
- Multiple consecutive subtherapeutic INRs (not just this single value)
Patient Education:
- Emphasize importance of adherence 3
- If a dose is missed, take it as soon as remembered on the same day
- Never double up doses the next day 3
- Maintain consistent vitamin K intake in diet 3
Follow-Up Strategy
At the 1-2 week recheck:
- If INR returns to 2.0-3.0: Continue current dose, resume routine monitoring intervals
- If INR remains 1.5-1.9: Consider small dose increase (5-20% of weekly dose) 4
- If INR <1.5: Investigate for non-adherence, drug interactions, dietary changes, or malabsorption
The key principle is that single isolated INR deviations in otherwise stable patients rarely require dose adjustments and often self-correct, especially when there's a clear explanation like a missed dose 1, 2, 5.